495 related articles for article (PubMed ID: 23598979)
1. CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.
Williams K; Motiani K; Giridhar PV; Kasper S
Exp Biol Med (Maywood); 2013 Mar; 238(3):324-38. PubMed ID: 23598979
[TBL] [Abstract][Full Text] [Related]
2. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.
Bourguignon LY; Shiina M; Li JJ
Adv Cancer Res; 2014; 123():255-75. PubMed ID: 25081533
[TBL] [Abstract][Full Text] [Related]
4. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
5. CD44 splice isoform switching determines breast cancer stem cell state.
Zhang H; Brown RL; Wei Y; Zhao P; Liu S; Liu X; Deng Y; Hu X; Zhang J; Gao XD; Kang Y; Mercurio AM; Goel HL; Cheng C
Genes Dev; 2019 Feb; 33(3-4):166-179. PubMed ID: 30692202
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan-CD44 axis orchestrates cancer stem cell functions.
Skandalis SS; Karalis TT; Chatzopoulos A; Karamanos NK
Cell Signal; 2019 Nov; 63():109377. PubMed ID: 31362044
[TBL] [Abstract][Full Text] [Related]
7. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
8. A CD44v
Hu J; Li G; Zhang P; Zhuang X; Hu G
Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
[TBL] [Abstract][Full Text] [Related]
9. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
[TBL] [Abstract][Full Text] [Related]
10. CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line.
Asai R; Tsuchiya H; Amisaki M; Makimoto K; Takenaga A; Sakabe T; Hoi S; Koyama S; Shiota G
Cancer Med; 2019 Feb; 8(2):773-782. PubMed ID: 30636370
[TBL] [Abstract][Full Text] [Related]
11. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.
Bourguignon LY; Zhu D; Zhu H
Front Biosci; 1998 Jul; 3():d637-49. PubMed ID: 9634539
[TBL] [Abstract][Full Text] [Related]
12. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
Olsson E; Honeth G; Bendahl PO; Saal LH; Gruvberger-Saal S; Ringnér M; Vallon-Christersson J; Jönsson G; Holm K; Lövgren K; Fernö M; Grabau D; Borg A; Hegardt C
BMC Cancer; 2011 Sep; 11():418. PubMed ID: 21957977
[TBL] [Abstract][Full Text] [Related]
13. Role of Pericellular Matrix in the Regulation of Cancer Stemness.
Avnet S; Cortini M
Stem Cell Rev Rep; 2016 Aug; 12(4):464-75. PubMed ID: 27193782
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-CD44 interactions as potential targets for cancer therapy.
Misra S; Heldin P; Hascall VC; Karamanos NK; Skandalis SS; Markwald RR; Ghatak S
FEBS J; 2011 May; 278(9):1429-43. PubMed ID: 21362138
[TBL] [Abstract][Full Text] [Related]
15. JNK Signaling in Stem Cell Self-Renewal and Differentiation.
Semba T; Sammons R; Wang X; Xie X; Dalby KN; Ueno NT
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283767
[TBL] [Abstract][Full Text] [Related]
16. CD44: A Multifunctional Mediator of Cancer Progression.
Hassn Mesrati M; Syafruddin SE; Mohtar MA; Syahir A
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944493
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth.
Pietras A; Katz AM; Ekström EJ; Wee B; Halliday JJ; Pitter KL; Werbeck JL; Amankulor NM; Huse JT; Holland EC
Cell Stem Cell; 2014 Mar; 14(3):357-69. PubMed ID: 24607407
[TBL] [Abstract][Full Text] [Related]
18. Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis.
Bourrguignon LY; Iida N; Welsh CF; Zhu D; Krongrad A; Pasquale D
J Neurooncol; 1995 Dec; 26(3):201-8. PubMed ID: 8750186
[TBL] [Abstract][Full Text] [Related]
19. The Role of CD44 and Cancer Stem Cells.
Wang L; Zuo X; Xie K; Wei D
Methods Mol Biol; 2018; 1692():31-42. PubMed ID: 28986884
[TBL] [Abstract][Full Text] [Related]
20. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]